International Journal of Nephrology / 2018 / Article / Tab 5 / Research Article
[Retracted] Management Practice, and Adherence and Its Contributing Factors among Patients with Chronic Kidney Disease at Tikur Anbessa Specialized Hospital: A Hospital Based Cross-Sectional Study Table 5 Profile of prescribed medications for chronic kidney disease patients attending the renal clinic of Tikur Anbessa Specialized Hospital.
Variables Stage of CKD 1 & 2 (n = 50) 3 (n = 88) 4 (n = 55) 5 (n = 63) Total (n=256) ACEI Enalapril 41 (82) 47 (53.4) 32(58.2) 28(44.4) 148 (57.8) CCB Amlodipine 21(42) 41(46.6) 25(45.5) 37(58.7) 124 (48.4) Nifedipine 8(16) 13(14.8) 17(30.9) 13(20.6) 51 (19.9) Diuretics Furosemide 14(28) 38(43.2) 30(54.5) 46(73) 128 (50) Hydrochlorothiazide 10(20) 23(26.1) 14(24.5) 22(34.9) 69 (27) Spironolactone 4(8) 12(13.6) 4(7.3) 10(15.9) 30 (11.7) -blocker Atenolol 6(12) 13(14.8) 10(18.2) 20(31.7) 49 (19.1) Metoprolol 4(8) 5(5.7) 3(5.5) 1(1.6) 13 (5.1) Carvedilol 0(0) 4(4.5) 1(1.8) 2(3.2) 7 (2.74) ARB Losartan 1(2) 2(2.3) 2(3.6) 0(0) 5(2) Antidiabetic Medications Insulin 14(28) 14(15.9) 20(36.4) 21(33.3) 69 (27) Metformin 9(18) 8(9.1) 4(7.3) 5(7.9) 26 (10.2) Glibenclamide 1(2) 5(5.7) 2(3.6) 0(0) 8 (3.1) Other medications ASA 8(16) 23(26.1) 20(36.4) 19(30.2) 70 (27.3) Statins 9(18) 18(20.5) 8(14.5) 15(23.8) 50 (19.5) Calcium supplement 1(2) 3(3.4) 6(10.9) 15(23.8) 25 (9.8) Iron 0(0) 4(4.5) 9(16.4) 15(23.8) 28 (10.9) Antibiotics 1(2) 5(5.7) 5(9.1) 5(7.9) 16 (6.3) Others 15(30) 23(26.1) 13(23.6) 17(27) 68 (26.6) Number of medications 3.2 ± 1.6 3.5 ± 1.7 4.3 ± 2 4.9 ± 2.9 3.9 ± 2.2
Phenobarbitone, warfarin, prednisolone, antiretroviral therapy, carbamazepine, and chlorpromazine; ACEI = angiotensin converting enzyme inhibitor; CCB = calcium channel blocker; ARB = angiotensin receptor blocker; ASA = Acetyl Salicylic Acid.